Literature DB >> 21286255

Gait in children with arthrogryposis multiplex congenita.

Marie Eriksson, Elena M Gutierrez-Farewik, Eva Broström, Asa Bartonek.   

Abstract

PURPOSE: Lower limb contractures and muscle weakness are common in children with arthrogryposis multiplex congenita (AMC). To enhance or facilitate ambulation, orthoses may be used. The aim of this study was to describe gait pattern among individuals wearing their habitual orthotic devices.
METHODS: Fifteen children with AMC, mean age 12.4 (4.3) years, with some lower limb involvement underwent 3-D gait analysis. Three groups were defined based on orthosis use; Group 1 used knee-ankle-foot orthoses with locked knee joints, Group 2 used ankle-foot orthoses or knee-ankle-foot orthoses with open knee joints and Group 3 used no orthoses.
RESULTS: The greatest trunk and pelvis movements in all planes and the greatest hip abduction were observed in Group 1, compared to Groups 2 and 3, as well as to the gait laboratory control group. Maximum hip extension was similar in Groups 1 and 2, but in Group 3, there was less hip extension and large deviations from the control data. Lower cadence and walking speed were observed in Group 1 than in Groups 2 and 3. The step length was similar in all groups and also with respect to the gait laboratory reference values.
CONCLUSIONS: Children with AMC were subdivided according to orthoses use. Kinematic data as recorded with 3-D gait analysis showed differences among the groups in trunk, pelvis and knee kinematics, and in cadence and walking speed. The step length was similar in all groups and to the gait laboratory reference values, which may be attributable to good hip extension strength in all participants.

Entities:  

Keywords:  AMC; Ambulation; Amyoplasia; Motion analysis

Year:  2010        PMID: 21286255      PMCID: PMC2811679          DOI: 10.1007/s11832-009-0234-1

Source DB:  PubMed          Journal:  J Child Orthop        ISSN: 1863-2521            Impact factor:   1.548


  18 in total

1.  The orthotic management of arthrogryphosis.

Authors:  J Florence
Journal:  Prosthet Orthot Int       Date:  1977-08       Impact factor: 1.895

2.  Arthrogryposis multiplex congenita. Long-term follow-up from birth until skeletal maturity.

Authors:  Alice Fassier; Philippe Wicart; Jean Dubousset; Raphaël Seringe
Journal:  J Child Orthop       Date:  2009-08-11       Impact factor: 1.548

3.  Management of knee deformity in classical arthrogryposis multiplex congenita (amyoplasia congenita).

Authors:  C Murray; J A Fixsen
Journal:  J Pediatr Orthop B       Date:  1997-07       Impact factor: 1.041

4.  Comprehensive management of arthrogryposis multiplex congenita.

Authors:  G H Thompson; R M Bilenker
Journal:  Clin Orthop Relat Res       Date:  1985-04       Impact factor: 4.176

5.  Foot and ankle deformities in arthrogryposis multiplex congenita.

Authors:  K J Guidera; J C Drennan
Journal:  Clin Orthop Relat Res       Date:  1985-04       Impact factor: 4.176

6.  Arthrogryposis. Pediatric review and habilitative aspects.

Authors:  G Hahn
Journal:  Clin Orthop Relat Res       Date:  1985-04       Impact factor: 4.176

7.  Ambulatory activity in youth with arthrogryposis: a cohort study.

Authors:  Erin R Dillon; Kristie F Bjornson; Kenneth M Jaffe; Judith G Hall; Kit Song
Journal:  J Pediatr Orthop       Date:  2009-03       Impact factor: 2.324

Review 8.  Arthrogryposis multiplex congenita (amyoplasia): an orthopaedic perspective.

Authors:  Wesley P Bevan; Judith G Hall; Micheal Bamshad; Lynn T Staheli; Kenneth M Jaffe; Kit Song
Journal:  J Pediatr Orthop       Date:  2007 Jul-Aug       Impact factor: 2.324

9.  Effects of carbon fibre spring orthoses on gait in ambulatory children with motor disorders and plantarflexor weakness.

Authors:  Asa Bartonek; Marie Eriksson; Elena M Gutierrez-Farewik
Journal:  Dev Med Child Neurol       Date:  2007-08       Impact factor: 5.449

10.  Associations between orthopaedic findings, ambulation and health-related quality of life in children with myelomeningocele.

Authors:  Aina J Danielsson; Asa Bartonek; Eric Levey; Kathleen McHale; Paul Sponseller; Helena Saraste
Journal:  J Child Orthop       Date:  2007-12-15       Impact factor: 1.548

View more
  8 in total

Review 1.  Management of hip contractures and dislocations in arthrogryposis.

Authors:  Stefano Stilli; Diego Antonioli; Manuele Lampasi; Onofrio Donzelli
Journal:  Musculoskelet Surg       Date:  2012-01-26

Review 2.  Management of knee deformities in children with arthrogryposis.

Authors:  Manuele Lampasi; Diego Antonioli; Onofrio Donzelli
Journal:  Musculoskelet Surg       Date:  2012-08-09

3.  Short-term functional outcome in children with arthrogryposis multiplex congenita after multiple surgeries at an early age.

Authors:  Moutasem M Obeidat; Ziad Audat; Wadah Khriesat
Journal:  J Multidiscip Healthc       Date:  2012-08-10

4.  Walking, orthoses and physical effort in a Swedish population with arthrogryposis.

Authors:  Marie Eriksson; Li Villard; Asa Bartonek
Journal:  J Child Orthop       Date:  2014-06-08       Impact factor: 1.548

5.  Test-retest reliability for performance-based outcome measures among individuals with arthrogryposis multiplex congenita.

Authors:  Jaclyn Megan Sions; Maureen Donohoe; Emma Haldane Beisheim-Ryan; Ryan Todd Pohlig; Tracy Michele Shank; Louise Reid Nichols
Journal:  BMC Musculoskelet Disord       Date:  2022-02-05       Impact factor: 2.362

6.  The use of orthoses and gait analysis in children with AMC.

Authors:  Åsa Bartonek
Journal:  J Child Orthop       Date:  2015-11-04       Impact factor: 1.548

7.  Arthrogryposis in infancy, multidisciplinary approach: case report.

Authors:  Anna Binkiewicz-Glinska; Agnieszka Sobierajska-Rek; Stanislaw Bakula; Jolanta Wierzba; Konrad Drewek; Ireneusz M Kowalski; Katarzyna Zaborowska-Sapeta
Journal:  BMC Pediatr       Date:  2013-11-11       Impact factor: 2.125

8.  Gait dynamics in the wide spectrum of children with arthrogryposis: a descriptive study.

Authors:  Marie Eriksson; Åsa Bartonek; Eva Pontén; Elena M Gutierrez-Farewik
Journal:  BMC Musculoskelet Disord       Date:  2015-12-09       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.